News Releases

Date	Title
11/7/2022	Genetron Health Announces Receipt of Notification from Nasdaq
10/12/2022	Genetron Health Reports Unaudited Second Quarter 2022 Financial Results
9/2/2022	Genetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
8/22/2022	Genetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
6/16/2022	Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day
6/15/2022	Genetron Health Receives CAP Accreditation for its Maryland Laboratory
6/2/2022	Genetron Health Reports Unaudited First Quarter 2022 Financial Results
6/2/2022	Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
6/1/2022	Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-Genes
5/23/2022	Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022
4/19/2022	Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD®
4/8/2022	Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022
4/7/2022	Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™’s potential in MRD Assay Developments
3/29/2022	Genetron Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results
3/21/2022	Genetron Health to Participate in the Credit Suisse Asian Investment Conference
3/9/2022	Genetron Health to Announce Fourth Quarter and Full Year 2021 Unaudited Financial Results and Host Investor Call on March 29, 2022
2/10/2022	Genetron Health Announces Companion Diagnostic Collaboration Agreement with HUTCHMED’s ORPATHYS® for NSCLC
1/31/2022	Genetron Health to Participate in Upcoming Investor Conferences
1/10/2022	Genetron Health Reiterates Full Year 2021 Revenue Guidance

Print Page

Email Alerts

RSS

Contact IR

Search